SCHEMBL5105697

SCHEMBL5105697

Cc1ccc(C(=O)NC2(C(=O)O)CCCCC2)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.51
HPGD P15428 5/20 0.51
POLB P06746 2/20 0.48
KLK7 P49862 1/20 0.47
NPC1 O15118 5/20 0.46
PKM P14618 5/20 0.46
RAB9A P51151 4/20 0.46
ALDH1A1 P00352 3/20 0.46
TP53 P04637 3/20 0.46
MAPT P10636 3/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
TSHR P16473 2/20 0.45
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5097601 0.78 NPC1 (0.48) SMN1; SMN2HPGDNPC1RAB9AALDH1A1
SCHEMBL1843420 0.75 KDM4E (0.52) SMN1; SMN2HPGDNPC1RAB9AALDH1A1
SCHEMBL1837001 0.72 KDM4E (0.47) SMN1; SMN2NPC1PKMRAB9AALDH1A1
SCHEMBL5098144 0.72 LMNA (0.52) SMN1; SMN2HPGDPOLBNPC1PKM
SCHEMBL5098012 0.72 MAPT (0.49) SMN1; SMN2NPC1PKMRAB9AALDH1A1
SCHEMBL5101564 0.72 POLB (0.55) SMN1; SMN2POLBNPC1RAB9ATP53
SCHEMBL1840233 0.72 RAB9A (0.55) SMN1; SMN2HPGDPOLBNPC1PKM
SCHEMBL5756689 0.71 ERAP1 (0.43) POLBALDH1A1
SCHEMBL1836676 0.71 CTSK (0.61) ALDH1A1HTTLMNA
SCHEMBL1840229 0.71 CTSK (0.50) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342027-B2 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2008-03-11 US disclosed
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof DONG-A PHARMACEUTICAL CO., LTD. (KR) 2005-10-20 US disclosed
WO-2004011457-A1 1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof CTRL, PRCP, CLPP SMN1; SMN2 4244/4885HPGD 842/4885POLB 4036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.